BioLine RX News

News

Ticker

BLRX.TA

ISIN

IL0011015182

Inntekter Nettoinntekt P/E P/S EBIT Dividende Innsiderkjøp Aksjer Markedsverdi Gjeld Forpliktelser Egenkapital AAQS Ansatte ROE ROA ROCE News Dokumenter

BioLine RX Eulerpool Nyheter

BioLine RX aksjenyheter

BioLine RX blir overvåket av journalister og investorer verden over. Vi samler de seneste BioLine RX nyhetene her.

20. mars ·
Benzinga
Top Wall Street Forecasters Revamp BioLineRx Expectations Ahead Of Q4 Earnings
26. februar ·
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
23. februar ·
Benzinga
Arbitrator Issues Final Award To BioLineRx, Denies All Claims By Biokine Therapeutics; Biokine To Pay Expenses And Legal Fees
29. november ·
Yahoo
BioLine Rx Ltd (BLRX) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial ...
25. november ·
Yahoo
BLRX: Stem Cell Mobilization Presentation at ASH
24. november ·
Yahoo
BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
24. november ·
SeekingAlpha
BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript
18. november ·
Yahoo
BioLineRx to Report Third Quarter 2025 Results on November 24, 2025
17. november ·
Yahoo
BioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types
30. september ·
Yahoo
BLRX: A Venture into GBM

BioLine RX aksjesaksmeldinger

BioLine RX publiserer regelmessig nyheter på selskapets nettsted som er relevante for investorer.

BioLine RX News 2026

Denne siden inneholder alle aktuelle nyheter, analyser og pressemeldinger for BioLine RX aksje (BLRX.TA, ISIN: IL0011015182). Dette inkluderer Eulerpool-nyheter, selskapets analyser og offisielle pressemeldinger. Data oppdateres regelmessig for å gi investorer en fullstendig oversikt over de seneste utviklingene hos BioLine RX.

BioLine RX Aksje

BioLine RX BioLine RX Ltd is a global biopharmaceutical company specializing in the development of novel therapies for cancer and other serious diseases. The company is headquartered in Israel and has offices in the United States and Europe.